25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

ZLSCF (Zyus) Stock Analysis
Buy, Hold or Sell?

Let's analyze Zyus together

I guess you are interested in ZYUS Life Sciences Corporation. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Zyus’s Financial Insights
  • 📈 Technical Analysis (TA) – Zyus’s Price Targets

I'm going to help you getting a better view of ZYUS Life Sciences Corporation. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about ZYUS Life Sciences Corporation

I send you an email if I find something interesting about ZYUS Life Sciences Corporation.

1. Quick Overview

1.1. Quick analysis of Zyus (30 sec.)










1.2. What can you expect buying and holding a share of Zyus? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.23
Expected worth in 1 year
$0.94
How sure are you?
66.7%

+ What do you gain per year?

Total Gains per Share
$0.72
Return On Investment
130.5%

For what price can you sell your share?

Current Price per Share
$0.55
Expected price per share
$0.52 - $0.6
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Zyus (5 min.)




Live pricePrice per Share (EOD)
$0.55

2.2. Growth of Zyus (5 min.)




Is Zyus growing?

Current yearPrevious yearGrowGrow %
How rich?$16.7m$3.4m$13.3m79.5%

How much money is Zyus making?

Current yearPrevious yearGrowGrow %
Making money-$30.9m-$17.9m-$13m-42.1%
Net Profit Margin-12,134.2%-8,274.2%--

How much money comes from the company's main activities?

2.3. Financial Health of Zyus (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Zyus?

Welcome investor! Zyus's management wants to use your money to grow the business. In return you get a share of Zyus.

First you should know what it really means to hold a share of Zyus. And how you can make/lose money.

Speculation

The Price per Share of Zyus is $0.55. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Zyus.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Zyus, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.23. Based on the TTM, the Book Value Change Per Share is $0.18 per quarter. Based on the YOY, the Book Value Change Per Share is $0.05 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Zyus.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.42-75.6%-0.42-75.6%-0.24-43.8%-0.30-54.4%-0.30-54.4%-0.30-54.4%
Usd Book Value Change Per Share0.1832.6%0.1832.6%0.058.4%0.0813.7%0.0813.7%0.0813.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.1832.6%0.1832.6%0.058.4%0.0813.7%0.0813.7%0.0813.7%
Usd Price Per Share0.59-0.59-0.00-0.20-0.20-0.20-
Price to Earnings Ratio-1.42--1.42-0.00--0.47--0.47--0.47-
Price-to-Total Gains Ratio3.29-3.29-3.29-3.29-3.29-
Price to Book Ratio2.61-2.61-0.00-0.87-0.87-0.87-
Price-to-Total Gains Ratio3.29-3.29-3.29-3.29-3.29-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.55
Number of shares1818
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.180.08
Usd Total Gains Per Share0.180.08
Gains per Quarter (1818 shares)326.31136.84
Gains per Year (1818 shares)1,305.22547.34
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10130512950547537
2026102600010951084
3039163905016421631
4052215210021892178
5065266515027372725
6078317820032843272
7091379125038313819
801044210430043794366
901174711735049264913
1001305213040054735460

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.03.00.00.0%0.03.00.00.0%0.03.00.00.0%
Book Value Change Per Share1.00.00.0100.0%2.00.01.066.7%2.00.01.066.7%2.00.01.066.7%2.00.01.066.7%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.03.00.0%0.00.03.00.0%0.00.03.00.0%
Total Gains per Share1.00.00.0100.0%2.00.01.066.7%2.00.01.066.7%2.00.01.066.7%2.00.01.066.7%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of ZYUS Life Sciences Corporation compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1790.1790%0.046+288%0.075+138%0.075+138%0.075+138%
Book Value Per Share--0.2260.2260%0.046+388%0.091+149%0.091+149%0.091+149%
Current Ratio--0.7090.7090%0.439+61%0.383+85%0.383+85%0.383+85%
Debt To Asset Ratio--0.4450.4450%0.927-52%0.457-3%0.457-3%0.457-3%
Debt To Equity Ratio--0.8010.8010%12.649-94%4.483-82%4.483-82%4.483-82%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--30423197.44030423197.4400%--30423197.4400%30423197.4400%30423197.4400%
Eps---0.416-0.4160%-0.241-42%-0.299-28%-0.299-28%-0.299-28%
Ev To Sales Ratio--119.322119.3220%--119.3220%119.3220%119.3220%
Free Cash Flow Per Share---0.179-0.1790%-0.099-44%-0.164-8%-0.164-8%-0.164-8%
Free Cash Flow To Equity Per Share---0.011-0.0110%-0.005-53%-0.045+302%-0.045+302%-0.045+302%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Market Cap40896732.800-7%43871040.64043871040.6400%-+100%14623680.213+200%14623680.213+200%14623680.213+200%
Net Profit Margin---121.342-121.3420%-82.742-32%-105.798-13%-105.798-13%-105.798-13%
Operating Margin----0%-56.0440%-18.6810%-18.6810%-18.6810%
Operating Ratio--50.49350.4930%58.822-14%73.540-31%73.540-31%73.540-31%
Pb Ratio2.436-7%2.6132.6130%-+100%0.871+200%0.871+200%0.871+200%
Pe Ratio-1.322+7%-1.418-1.4180%--100%-0.473-67%-0.473-67%-0.473-67%
Price Per Share0.550-7%0.5900.5900%-+100%0.197+200%0.197+200%0.197+200%
Price To Free Cash Flow Ratio-3.078+7%-3.302-3.3020%--100%-1.101-67%-1.101-67%-1.101-67%
Price To Total Gains Ratio3.064-7%3.2873.2870%--3.2870%3.2870%3.2870%
Quick Ratio--0.1540.1540%0.014+1002%0.056+175%0.056+175%0.056+175%
Return On Assets---1.023-1.0230%-0.381-63%-0.468-54%-0.468-54%-0.468-54%
Return On Equity---1.843-1.8430%-5.201+182%-2.348+27%-2.348+27%-2.348+27%
Total Gains Per Share--0.1790.1790%0.046+288%0.075+138%0.075+138%0.075+138%
Usd Book Value--16790009.60016790009.6000%3443862.400+388%6744624.000+149%6744624.000+149%6744624.000+149%
Usd Book Value Change Per Share--0.1790.1790%0.046+288%0.075+138%0.075+138%0.075+138%
Usd Book Value Per Share--0.2260.2260%0.046+388%0.091+149%0.091+149%0.091+149%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--30423197.44030423197.4400%--30423197.4400%30423197.4400%30423197.4400%
Usd Eps---0.416-0.4160%-0.241-42%-0.299-28%-0.299-28%-0.299-28%
Usd Free Cash Flow---13288035.200-13288035.2000%-7384582.400-44%-12181243.733-8%-12181243.733-8%-12181243.733-8%
Usd Free Cash Flow Per Share---0.179-0.1790%-0.099-44%-0.164-8%-0.164-8%-0.164-8%
Usd Free Cash Flow To Equity Per Share---0.011-0.0110%-0.005-53%-0.045+302%-0.045+302%-0.045+302%
Usd Market Cap40896732.800-7%43871040.64043871040.6400%-+100%14623680.213+200%14623680.213+200%14623680.213+200%
Usd Price Per Share0.550-7%0.5900.5900%-+100%0.197+200%0.197+200%0.197+200%
Usd Profit---30938102.400-30938102.4000%-17910844.800-42%-21962219.733-29%-21962219.733-29%-21962219.733-29%
Usd Revenue--254966.400254966.4000%216467.200+18%207266.133+23%207266.133+23%207266.133+23%
Usd Total Gains Per Share--0.1790.1790%0.046+288%0.075+138%0.075+138%0.075+138%
 EOD+2 -6MRQTTM+0 -0YOY+19 -123Y+21 -105Y+21 -1010Y+21 -10

3.3 Fundamental Score

Let's check the fundamental score of ZYUS Life Sciences Corporation based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.322
Price to Book Ratio (EOD)Between0-12.436
Net Profit Margin (MRQ)Greater than0-121.342
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.154
Current Ratio (MRQ)Greater than10.709
Debt to Asset Ratio (MRQ)Less than10.445
Debt to Equity Ratio (MRQ)Less than10.801
Return on Equity (MRQ)Greater than0.15-1.843
Return on Assets (MRQ)Greater than0.05-1.023
Total2/10 (20.0%)

3.4 Technical Score

Let's check the technical score of ZYUS Life Sciences Corporation based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.550
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About ZYUS Life Sciences Corporation

ZYUS Life Sciences Corporation manufactures and distributes cannabinoid-based therapeutics and product candidates in Canada and internationally. The company offers cannabinoid oils, softgel capsules, and topical creams. ZYUS Life Sciences Corporation was founded in 2018 and is based in Saskatoon, Canada.

Fundamental data was last updated by Penke on 2025-04-30 02:34:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Zyus earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Zyus to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -12,134.2% means that $-121.34 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of ZYUS Life Sciences Corporation:

  • The MRQ is -12,134.2%. The company is making a huge loss. -2
  • The TTM is -12,134.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-12,134.2%TTM-12,134.2%0.0%
TTM-12,134.2%YOY-8,274.2%-3,860.0%
TTM-12,134.2%5Y-10,579.8%-1,554.4%
5Y-10,579.8%10Y-10,579.8%0.0%
4.3.1.2. Return on Assets

Shows how efficient Zyus is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Zyus to the Drug Manufacturers - Specialty & Generic industry mean.
  • -102.3% Return on Assets means that Zyus generated $-1.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of ZYUS Life Sciences Corporation:

  • The MRQ is -102.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -102.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-102.3%TTM-102.3%0.0%
TTM-102.3%YOY-38.1%-64.2%
TTM-102.3%5Y-46.8%-55.5%
5Y-46.8%10Y-46.8%0.0%
4.3.1.3. Return on Equity

Shows how efficient Zyus is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Zyus to the Drug Manufacturers - Specialty & Generic industry mean.
  • -184.3% Return on Equity means Zyus generated $-1.84 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of ZYUS Life Sciences Corporation:

  • The MRQ is -184.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -184.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-184.3%TTM-184.3%0.0%
TTM-184.3%YOY-520.1%+335.8%
TTM-184.3%5Y-234.8%+50.5%
5Y-234.8%10Y-234.8%0.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of ZYUS Life Sciences Corporation.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Zyus is operating .

  • Measures how much profit Zyus makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Zyus to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of ZYUS Life Sciences Corporation:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-5,604.4%+5,604.4%
TTM-5Y-1,868.1%+1,868.1%
5Y-1,868.1%10Y-1,868.1%0.0%
4.3.2.2. Operating Ratio

Measures how efficient Zyus is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 50.49 means that the operating costs are $50.49 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of ZYUS Life Sciences Corporation:

  • The MRQ is 50.493. The company is inefficient in keeping operating costs low. -1
  • The TTM is 50.493. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ50.493TTM50.4930.000
TTM50.493YOY58.822-8.329
TTM50.4935Y73.540-23.047
5Y73.54010Y73.5400.000
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of ZYUS Life Sciences Corporation.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Zyus is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 0.71 means the company has $0.71 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of ZYUS Life Sciences Corporation:

  • The MRQ is 0.709. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.709. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.709TTM0.7090.000
TTM0.709YOY0.439+0.270
TTM0.7095Y0.383+0.326
5Y0.38310Y0.3830.000
4.4.3.2. Quick Ratio

Measures if Zyus is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Zyus to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.15 means the company can pay off $0.15 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of ZYUS Life Sciences Corporation:

  • The MRQ is 0.154. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.154. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.154TTM0.1540.000
TTM0.154YOY0.014+0.140
TTM0.1545Y0.056+0.098
5Y0.05610Y0.0560.000
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of ZYUS Life Sciences Corporation.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Zyus assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Zyus to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.44 means that Zyus assets are financed with 44.5% credit (debt) and the remaining percentage (100% - 44.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of ZYUS Life Sciences Corporation:

  • The MRQ is 0.445. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.445. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.445TTM0.4450.000
TTM0.445YOY0.927-0.482
TTM0.4455Y0.457-0.012
5Y0.45710Y0.4570.000
4.5.4.2. Debt to Equity Ratio

Measures if Zyus is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Zyus to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 80.1% means that company has $0.80 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of ZYUS Life Sciences Corporation:

  • The MRQ is 0.801. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.801. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.801TTM0.8010.000
TTM0.801YOY12.649-11.848
TTM0.8015Y4.483-3.683
5Y4.48310Y4.4830.000
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Zyus generates.

  • Above 15 is considered overpriced but always compare Zyus to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -1.42 means the investor is paying $-1.42 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of ZYUS Life Sciences Corporation:

  • The EOD is -1.322. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.418. Based on the earnings, the company is expensive. -2
  • The TTM is -1.418. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.322MRQ-1.418+0.096
MRQ-1.418TTM-1.4180.000
TTM-1.418YOY--1.418
TTM-1.4185Y-0.473-0.945
5Y-0.47310Y-0.4730.000
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of ZYUS Life Sciences Corporation:

  • The EOD is -3.078. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -3.302. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3.302. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.078MRQ-3.302+0.224
MRQ-3.302TTM-3.3020.000
TTM-3.302YOY--3.302
TTM-3.3025Y-1.101-2.201
5Y-1.10110Y-1.1010.000
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Zyus is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of ZYUS Life Sciences Corporation:

  • The EOD is 2.436. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.613. Based on the equity, the company is underpriced. +1
  • The TTM is 2.613. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.436MRQ2.613-0.177
MRQ2.613TTM2.6130.000
TTM2.613YOY-+2.613
TTM2.6135Y0.871+1.742
5Y0.87110Y0.8710.000
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CAD. All numbers in thousands.

Summary
Total Assets41,627
Total Liabilities18,513
Total Stockholder Equity23,114
 As reported
Total Liabilities 18,513
Total Stockholder Equity+ 23,114
Total Assets = 41,627

Assets

Total Assets41,627
Total Current Assets9,388
Long-term Assets32,239
Total Current Assets
Cash And Cash Equivalents 3,978
Short-term Investments 1,874
Net Receivables 161
Inventory 2,042
Other Current Assets 867
Total Current Assets  (as reported)9,388
Total Current Assets  (calculated)8,922
+/- 466
Long-term Assets
Property Plant Equipment 13,894
Goodwill 5,871
Intangible Assets 12,322
Long-term Assets Other 152
Long-term Assets  (as reported)32,239
Long-term Assets  (calculated)32,239
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities13,244
Long-term Liabilities5,269
Total Stockholder Equity23,114
Total Current Liabilities
Short Long Term Debt 6,149
Accounts payable 3,435
Total Current Liabilities  (as reported)13,244
Total Current Liabilities  (calculated)9,584
+/- 3,660
Long-term Liabilities
Long term Debt 637
Capital Lease Obligations Min Short Term Debt3,020
Long-term Liabilities  (as reported)5,269
Long-term Liabilities  (calculated)3,657
+/- 1,612
Total Stockholder Equity
Total Stockholder Equity (as reported)23,114
Total Stockholder Equity (calculated)0
+/- 23,114
Other
Capital Stock154,088
Common Stock Shares Outstanding 70,847
Net Debt 2,808
Net Invested Capital 29,900
Net Working Capital -3,856
Property Plant and Equipment Gross 27,455



6.2. Balance Sheets Structured

Currency in CAD. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-31
> Total Assets 
0
0
64,712
41,627
41,62764,71200
   > Total Current Assets 
0
0
6,266
9,388
9,3886,26600
       Cash And Cash Equivalents 
0
0
212
3,978
3,97821200
       Short-term Investments 
0
0
0
1,874
1,874000
       Net Receivables 
0
0
199
161
16119900
       Other Current Assets 
0
0
748
867
86774800
   > Long-term Assets 
0
0
58,447
32,239
32,23958,44700
       Property Plant Equipment 
0
0
17,032
13,894
13,89417,03200
       Goodwill 
0
0
5,871
5,871
5,8715,87100
       Intangible Assets 
0
0
35,388
12,322
12,32235,38800
       Other Assets 
0
0
156
0
015600
> Total Liabilities 
0
0
59,971
18,513
18,51359,97100
   > Total Current Liabilities 
0
0
14,268
13,244
13,24414,26800
       Short Long Term Debt 
0
0
899
6,149
6,14989900
       Accounts payable 
0
0
8,512
3,435
3,4358,51200
   > Long-term Liabilities 
0
0
45,703
5,269
5,26945,70300
       Capital Lease Obligations Min Short Term Debt
0
0
3,206
3,020
3,0203,20600
> Total Stockholder Equity
0
0
4,741
23,114
23,1144,74100
   Common Stock
0
0
92,673
0
092,67300
   Retained Earnings Total Equity0000
   Accumulated Other Comprehensive Income 0000
   Capital Surplus 0000
   Treasury Stock0000
   Other Stockholders Equity 
0
0
4,035
0
04,03500



6.3. Balance Sheets

Currency in CAD. All numbers in thousands.




6.4. Cash Flows

Currency in CAD. All numbers in thousands.




6.5. Income Statements

Currency in CAD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in CAD. All numbers in thousands.

Gross Profit (+$)
totalRevenue351
Cost of Revenue-180
Gross Profit171171
 
Operating Income (+$)
Gross Profit171
Operating Expense-17,543
Operating Income-17,192-17,372
 
Operating Expense (+$)
Research Development1,309
Selling General Administrative12,596
Selling And Marketing Expenses-
Operating Expense17,54313,905
 
Net Interest Income (+$)
Interest Income-
Interest Expense-3,272
Other Finance Cost-573
Net Interest Income-3,845
 
Pretax Income (+$)
Operating Income-17,192
Net Interest Income-3,845
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-48,43910,210
EBIT - interestExpense = -3,272
-42,591
-39,319
Interest Expense3,272
Earnings Before Interest and Taxes (EBIT)--45,167
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-48,439
Tax Provision--5,848
Net Income From Continuing Ops-42,591-42,591
Net Income-42,591
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-27,4023,845
 

Technical Analysis of Zyus
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Zyus. The general trend of Zyus is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Zyus's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Zyus Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of ZYUS Life Sciences Corporation.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.6 < 0.6 < 0.6.

The bearish price targets are: 0.52 > 0.52 > 0.52.

Know someone who trades $ZLSCF? Share this with them.👇

ZYUS Life Sciences Corporation Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of ZYUS Life Sciences Corporation. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

ZYUS Life Sciences Corporation Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of ZYUS Life Sciences Corporation.

ZYUS Life Sciences Corporation Daily Moving Average Convergence/Divergence (MACD) ChartZYUS Life Sciences Corporation Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of ZYUS Life Sciences Corporation. The current adx is .

ZYUS Life Sciences Corporation Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of ZYUS Life Sciences Corporation.

ZYUS Life Sciences Corporation Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of ZYUS Life Sciences Corporation.

ZYUS Life Sciences Corporation Daily Relative Strength Index (RSI) ChartZYUS Life Sciences Corporation Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of ZYUS Life Sciences Corporation.

ZYUS Life Sciences Corporation Daily Stochastic Oscillator ChartZYUS Life Sciences Corporation Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of ZYUS Life Sciences Corporation.

ZYUS Life Sciences Corporation Daily Commodity Channel Index (CCI) ChartZYUS Life Sciences Corporation Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of ZYUS Life Sciences Corporation.

ZYUS Life Sciences Corporation Daily Chande Momentum Oscillator (CMO) ChartZYUS Life Sciences Corporation Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of ZYUS Life Sciences Corporation.

ZYUS Life Sciences Corporation Daily Williams %R ChartZYUS Life Sciences Corporation Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of ZYUS Life Sciences Corporation.

ZYUS Life Sciences Corporation Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of ZYUS Life Sciences Corporation.

ZYUS Life Sciences Corporation Daily Average True Range (ATR) ChartZYUS Life Sciences Corporation Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of ZYUS Life Sciences Corporation.

ZYUS Life Sciences Corporation Daily On-Balance Volume (OBV) ChartZYUS Life Sciences Corporation Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of ZYUS Life Sciences Corporation.

ZYUS Life Sciences Corporation Daily Money Flow Index (MFI) ChartZYUS Life Sciences Corporation Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for ZYUS Life Sciences Corporation.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-01-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-01-06STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-01-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-01-22MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-01-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-01-27STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-02-14MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-17STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-19RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-03-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-10WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-04-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

ZYUS Life Sciences Corporation Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of ZYUS Life Sciences Corporation based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.550
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Zyus with someone you think should read this too:
  • Are you bullish or bearish on Zyus? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Zyus? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about ZYUS Life Sciences Corporation

I send you an email if I find something interesting about ZYUS Life Sciences Corporation.


Comments

How you think about this?

Leave a comment

Stay informed about ZYUS Life Sciences Corporation.

Receive notifications about ZYUS Life Sciences Corporation in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.